Bromocriptine Mesylate and Insulin Glargine (U-100) Vials
Determining the interaction of Bromocriptine Mesylate and Insulin Glargine (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Mesylate-Insulin Glargine (U-300) Pens
- Bromocriptine Mesylate-Insulin glargine and lixisenatide
- Bromocriptine Mesylate-Insulin glargine and lixisenatide Subcutaneous
- Bromocriptine Mesylate-Insulin glargine, recombinant Subcutaneous
- Bromocriptine Mesylate-Insulin glulisine
- Bromocriptine Mesylate-Insulin Glulisine (Cartridges and Pens)
- Insulin Glargine (U-100) Vials-Brompheniramine
- Insulin Glargine (U-100) Vials-Brompheniramine and codeine
- Insulin Glargine (U-100) Vials-Brompheniramine and phenylephrine
- Insulin Glargine (U-100) Vials-Brompheniramine and Phenylephrine Chewable Tablets
- Insulin Glargine (U-100) Vials-Brompheniramine and Phenylephrine Liquid
- Insulin Glargine (U-100) Vials-Brompheniramine and Phenylephrine Suspension